Related Experiment Video

Updated: Jul 15, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Increasing antiretroviral drug access for children with HIV infection

, Peter L Havens, Diana M Gibb

    Pediatrics
    |April 4, 2007
    PubMed

    Insights

    Scaling up pediatric HIV prevention and treatment in resource-limited settings faces challenges. Improving infant testing, practitioner training, and developing child-friendly antiretroviral formulations are crucial for effective pediatric HIV care.

    Area of Science:

    • Global Health
    • Pediatric Infectious Diseases
    • HIV/AIDS Research

    Background:

    • Significant progress in pediatric HIV prevention and antiretroviral therapy (ART) in high-income nations.
    • Persistent barriers hinder the scale-up of HIV prevention and treatment for children in low-resource settings worldwide.

    Purpose of the Study:

    • To identify key challenges and propose solutions for improving pediatric HIV care in resource-limited areas.
    • To address the need for accessible and effective HIV interventions for children globally.

    Main Methods:

    • Review of current strategies and challenges in pediatric HIV management.
    • Analysis of barriers related to diagnostics, healthcare worker training, and drug formulations.

    Main Results:

    • Inadequate availability of appropriate infant HIV testing technologies.
    • Shortage of trained healthcare practitioners skilled in pediatric HIV care.
    • Lack of suitable, affordable, and easy-to-administer antiretroviral drug formulations for children.

    Conclusions:

    • Wider access to infant HIV testing and enhanced practitioner training are essential.
    • Development of pediatric-friendly antiretroviral formulations (e.g., smaller pills, crushable tablets) is critical.
    • Focusing on practical drug formulations may be more beneficial than solely developing liquid forms for resource-limited settings.

    More Related Videos

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

    Published on: April 9, 2014

    New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals09:27

    New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

    Published on: May 30, 2013

    Related Concept Videos

    Retrovirus Life Cycles01:10

    Retrovirus Life Cycles

    Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Immunodeficiency Diseases01:25

    Immunodeficiency Diseases

    Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
    There are three main causes of immunodeficiency disorders...